Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (11)

2022

  1. Genetic susceptibility to telomere shortening through the rs2293607 polymorphism is associated with a greater risk of alcohol use disorder

    Mechanisms of ageing and development, Vol. 206, pp. 111693

2021

  1. Telomere length shortening associated with cataract in younger adults publica

    Revista Mexicana de Oftalmologia, Vol. 95, Núm. 1, pp. 1-7

2020

  1. Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Genetic susceptibility in head and neck squamous cell carcinoma in a spanish population

    Cancers, Vol. 11, Núm. 4

2018

  1. Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib

    Oncotarget, Vol. 9, Núm. 97, pp. 36894-36905

2017

  1. A novel capillary nano-immunoassay for assessing androgen receptor splice variant 7 in plasma. Correlation with CD133 antigen expression in circulating tumor cells. A pilot study in prostate cancer patients

    Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1350-1357

  2. Analysis of autophagy gene polymorphisms in Spanish patients with head and neck squamous cell carcinoma

    Scientific Reports, Vol. 7, Núm. 1

  3. Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors

    Scientific Reports, Vol. 7

  4. Study of association between pre-senile cataracts and rs11615 of ERCC1, rs13181 of ERCC2, and rs25487 of XRCC1 polymorphisms in a Spanish population

    Ophthalmic Genetics, Vol. 38, Núm. 4, pp. 314-319

2016

  1. Epidemiological characteristics of a Spanish cohort of patients diagnosed with squamous cell carcinoma of head and neck: distribution of risk factors by tumor location

    Clinical and Translational Oncology, Vol. 18, Núm. 11, pp. 1114-1122

  2. Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population

    Oral Oncology, Vol. 63, pp. 38-43